Brian Lundstrom joins Windy Hill Medical as Chief Executive Officer

Life Science Partner recruits former Senior Vice President, Business and Commercial Development from ACADIA Pharmaceuticals

Life Science Partner announces the recruitment of Brian Lundstrom, an experienced biopharmaceutical business development executive, to Windy Hill Medical to become Chief Executive Officer for the company.  Windy Hill Medical is a California-based medical device and pharmaceutical company focused on the development of products to reduce the risk of developing breast cancer in patients deemed to be at high risk.

In Lundstrom’s previous role at ACADIA, a San Diego-based biopharmaceutical company developing small molecule therapeutics for the central nervous system, he was responsible for developing partnerships, particularly with Asian and European pharmaceutical companies, for the company’s four clinical-stage and preclinical programs.  Prior to joining ACADIA, Lundstrom served as Vice President of Business Development and Humanized Polyclonal Antibody Program Manager for Genzyme Corporation in the areas of Oncology, Hematology Transplantation and Immunology.  In his new role as Chief Executive Officer, he will lead the Company through an additional round of financing, the development and expansion of the clinical trial program, and commercialization of its product portfolio.

“Lundstrom is an experienced and effective global biopharmaceutical manager with a broad background in business development and partnering,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “With his passion and experience, he will serve Windy Hill well in its mission to bring lasting improvements for patients with early-stage breast cancer.”

Lundstrom earned his Master of Science degree in Chemical Engineering with an immunology and molecular biology focus from the Danish Technical University in Lyngby, Denmark.  He attended the Copenhagen Business School and earned a diploma in Economics in International Management.  Lundstrom received his PhD in Biochemistry from Odense University and then attended the Monterey Institute of International Studies in Monterey, CA for an MBA program.